Maraviroc is an active pharmaceutical ingredient used as an antiretroviral compound. It functions by blocking the interaction between HIV-1 gp120 and the CCR5 chemokine receptor, preventing entry of CCR5-tropic HIV-1 into cells.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 376348-65-1
Nafenopin
pharmaceutical raw material
Ifosfamide
pharmaceutical raw material
Gonadorelin acetate impurity C
pharmaceutical raw material
Betamethasone
pharmaceutical raw material
4,4-difluoro-N-[(1S)-3-[(1S,5R)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide
GSNHKUDZZFZSJB-HLMSNRGBSA-N
CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C